Effects of Different Immunosuppressive Drugs on Incretins in Renal Transplant Patients
JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION, vol.112, no.3, pp.250-257, 2020 (SCI-Expanded, Scopus)
- Publication Type: Article / Article
- Volume: 112 Issue: 3
- Publication Date: 2020
- Doi Number: 10.1016/j.jnma.2020.03.012
- Journal Name: JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION
- Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, BIOSIS, CAB Abstracts, CINAHL, EMBASE, Gender Studies Database, International Pharmaceutical Abstracts, MEDLINE, Psycinfo, Veterinary Science Database
- Page Numbers: pp.250-257
- Keywords: Incretin, Glucagon-like peptide-1, Glucose dependent insulinotropic polypeptide, Post-transplant diabetes, Renal transplantation, GLUCAGON-LIKE PEPTIDE-1, INSULIN SENSITIVITY, SECRETION, GLUCOSE, RELEASE
- Akdeniz University Affiliated: Yes
Abstract
Background: Immunosuppressive drugs used in transplantation patients, may contribute to the development of post-transplant diabetes mellitus through their possible adverse effects on incretins. We aimed to compare the effects of different immunosuppressive drugs used in renal transplantation patients on glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) levels.